Update from CBER FDA
Friday, March 3, 2017: 12:45 PM-2:00 PM
Georgia World Congress Center, Building B, Level 2, Room B206
1.25 CME/CE
Jay E. Slater , MD

Learning Objectives:
  1. Identify FDA standards in approving new allergen immunotherapy products, including use of challenge procedures and statistical standards
  2. Discuss considerations for conduct of trials for novel food allergy immunotherapy products
  3. Discuss considerations for conduct of trials for products that prevent the development of allergic disease
This Session Will Use Audience Response Technology.
12:45 PM
Year-in-Review at CBER FDA
Ronald L. Rabin, MD FAAAAI
1:00 PM
Lessons Learned from Recent Allergenic Product Approvals
Joohee Lee, MD
1:15 PM
Approval of Food Allergy Immunotherapy Products
Kathleen S. Hise, MD
1:30 PM
Approval of Products for the Prevention of Allergy
Suyoung Tina Chang, MD
1:45 PM
Question & Answer
See more of: Session